Anavex Reports Sigma Receptor Review Published in Leading Journal

Geneva, Switzerland — August 27, 2009 — Anavex Life Sciences Corp. (“ANAVEX” or the “Company”) (OTCBB: AVXL) reports the publication of a comprehensive review of the pharmacology of sigma receptors and their possible clinical application in the peer-reviewed Journal of Pharmacology & Therapeutics. The paper provides new insight into sigma-1 receptors and their potential ability…